Addendum: MCC950 closes the active conformation of NLRP3 to an inactive state

被引：0
|
作者：
Ana Tapia-Abellán
Diego Angosto-Bazarra
Helios Martínez-Banaclocha
Carlos de Torre-Minguela
Jose P. Cerón-Carrasco
Horacio Pérez-Sánchez
Juan I. Arostegui
Pablo Pelegrin
机构：
[1] University Clinical Hospital Virgen de la Arrixaca,Biomedical Research Institute of Murcia (IMIB
[2] Computer Engineering Department,Arrixaca)
[3] Universidad Católica de Murcia (UCAM),Bioinformatics and High Performance Computing Research Group (BIO
[4] Hospital Clinic-IDIBAPS,HPC)
来源：
Nature Chemical Biology | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An Addendum to this paper has been published: https://doi.org/10.1038/s41589-021-00741-6
引用
收藏
页码：361 / 361
相关论文
共 50 条
  • [1] MCC950 closes the active conformation of NLRP3 to an inactive state
    Ana Tapia-Abellán
    Diego Angosto-Bazarra
    Helios Martínez-Banaclocha
    Carlos de Torre-Minguela
    Jose P. Cerón-Carrasco
    Horacio Pérez-Sánchez
    Juan I. Arostegui
    Pablo Pelegrin
    Nature Chemical Biology, 2019, 15 : 560 - 564
  • [2] MCC950 closes the active conformation of NLRP3 to an inactive state
    Tapia-Abelian, Ana
    Angosto-Bazarra, Diego
    Martinez-Banaclocha, Helios
    de Torre-Minguela, Carlos
    Ceron-Carrasco, Jose P.
    Perez-Sanchez, Horacio
    Arostegui, Juan, I
    Pelegrin, Pablo
    NATURE CHEMICAL BIOLOGY, 2019, 15 (06) : 560 - +
  • [3] MCC950 closes the active conformation of NLRP3 to an inactive state (vol 15, pg 560, 2019)
    Tapia-Abellan, Ana
    Angosto-Bazarra, Diego
    Martinez-Banaclocha, Helios
    de Torre-Minguela, Carlos
    Ceron-Carrasco, Jose P.
    Perez-Sanchez, Horacio
    Arostegui, Juan I.
    Pelegrin, Pablo
    NATURE CHEMICAL BIOLOGY, 2021, 17 (03) : 361 - 361
  • [4] Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3
    Zhao, Heng
    Kumar, Praveen
    Sobreira, Tiago Jose Paschoal
    Smith, Mackenzie
    Novick, Steven
    Johansson, Anders
    Luchniak, Anna
    Zhang, Andrew
    Woollard, Kevin J.
    Larsson, Niklas
    Kawatkar, Aarti
    ACS CHEMICAL BIOLOGY, 2024, 19 (04) : 962 - 972
  • [5] Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
    Li, Hao
    Guan, Yanling
    Liang, Bo
    Ding, Peng
    Hou, Xin
    Wei, Wei
    Ma, Yang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 928
  • [6] Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
    Wu, Danbin
    Chen, Yefei
    Sun, Yingxin
    Gao, Qing
    Li, Huhu
    Yang, Zhengfei
    Wang, Yangxue
    Jiang, Xijuan
    Yu, Bin
    INFLAMMATION, 2020, 43 (01) : 17 - 23
  • [7] Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
    Danbin Wu
    Yefei Chen
    Yingxin Sun
    Qing Gao
    Huhu Li
    Zhengfei Yang
    Yangxue Wang
    Xijuan Jiang
    Bin Yu
    Inflammation, 2020, 43 : 17 - 23
  • [8] Blockage of the NLRP3 inflammasome by MCC950 inhibits migration and invasion in adenomyosis
    Liu, Yanping
    Jiang, Zhou
    Zhang, Lu
    Tian, Wei
    Lin, Aimin
    Li, Mingjiang
    REPRODUCTIVE BIOMEDICINE ONLINE, 2024, 49 (04)
  • [9] THE EFFECT OF NOVEL COMPOUND MCC950 ON THE NLRP3 INFLAMMASOME IN THE RA JOINT
    McGarry, T.
    Robertson, A. A.
    Orr, C.
    Coll, R. C.
    Cooper, M. A.
    O'Neill, L. A.
    Veale, D. J.
    Fearon, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 202 - 202
  • [10] MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel potential therapeutic for NLRP3 driven diseases
    Coll, Rebecca C.
    Robertson, Avril A. B.
    Chae, Jae Jin
    Higgins, Sarah C.
    Dungan, Lara S.
    Munoz-Planillo, Raul
    Monks, Brian G.
    Croker, Daniel E.
    Sutton, Caroline E.
    Stutz, Andrea
    Nunez, Gabriel
    Latz, Eicke
    Kastner, Daniel L.
    Mills, Kingston H. G.
    Masters, Seth L.
    Schroder, Kate
    Cooper, Matt A.
    O'Neill, Luke A. J.
    CYTOKINE, 2014, 70 (01) : 35 - 35
12345